Neptune Technologies & Bioressources Company Profile (TSE:NTB)

About Neptune Technologies & Bioressources

Neptune Technologies & Bioressources logoNeptune Technologies & Bioressources Inc is a Canada-based biotechnology company. The Company is engaged primarily in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids (PUFAs). The Company has three operating segments: Neptune, Acasti Pharma Inc. and NeuroBioPharm Inc. The Company's Neptune segment produces and commercializes nutraceutical products. The Company's Acasti Pharma Inc. segment develops and commercializes medical food and pharmaceutical products for cardiovascular diseases. The Company's NeuroBioPharm Inc. segment develops medical food and pharmaceutical products for neurological diseases. The Company's lead product, Neptune Krill Oil (NKO), come in capsule form and serve as a dietary supplement to consumers. The Company's other nutraceutical products include Ecokrill Oil (EKO), Rimfrost Oil, Neptune Krill Aquatein ( NKA) and New Formulation Derived from NKO, which include NKO Beat, NKO Flex and NKO Focus.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: TSE
  • Symbol: NTB
  • CUSIP:
Key Metrics:
  • Previous Close: $1.27
  • 50 Day Moving Average: $1.31
  • 200 Day Moving Average: $1.37
  • Trailing P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $98.99M
  • Outstanding Shares: 77,945,000
Additional Links:

Analyst Ratings

Consensus Ratings for Neptune Technologies & Bioressources (TSE:NTB) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Neptune Technologies & Bioressources (TSE:NTB)
Show:
No equities research coverage for this company has been tracked by MarketBeat.com

Earnings

Earnings History for Neptune Technologies & Bioressources (TSE:NTB)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/12/2016        
7/16/2014($0.08)($0.06)ViewN/AView Earnings Details
5/22/2014($0.08)($0.08)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neptune Technologies & Bioressources (TSE:NTB)
Current Year EPS Consensus Estimate: $0.01 EPS

Dividends

Dividend History for Neptune Technologies & Bioressources (TSE:NTB)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neptune Technologies & Bioressources (TSE:NTB)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
2/1/2016James Stuart HamiltonDirectorBuy4,000C$1.58C$6,320.00
1/28/2016James Stuart HamiltonDirectorBuy2,000C$1.55C$3,100.00
1/18/2016Mario ParadisInsiderBuy10,000C$1.50C$15,000.00
1/15/2016John Morris MoretzDirectorBuy700,651C$1.05C$735,683.55
1/15/2016Mario ParadisInsiderBuy40,000C$1.54C$61,672.00
10/29/2015John Morris MoretzDirectorBuy26,044C$1.08C$28,101.48
10/28/2015John Morris MoretzDirectorBuy24,500C$1.12C$27,538.00
10/27/2015John Morris MoretzDirectorBuy5,500C$1.09C$6,006.00
10/23/2015John Morris MoretzDirectorBuy50,000C$1.17C$58,385.00
10/5/2015John Morris MoretzDirectorBuy13,692C$1.24C$16,991.77
10/2/2015John Morris MoretzDirectorBuy33,900C$1.23C$41,663.10
9/15/2015John Morris MoretzDirectorBuy9,001C$1.24C$11,161.24
7/22/2015John Morris MoretzDirectorBuy2,800C$1.34C$3,750.60
7/21/2015John Morris MoretzDirectorBuy21,654C$1.34C$28,975.22
7/16/2015Pierre LemieuxDirectorSell6,250C$1.62C$10,135.00
6/8/2015Pierre FitzgibbonDirectorBuy47,500C$1.70C$80,693.00
2/17/2015Reed TucksonDirectorBuy10,800C$1.85C$19,931.40
2/13/2015Michel TimperioInsiderSell10,000C$2.19C$21,870.00
2/6/2015André GodinInsiderSell5,000C$2.14C$10,700.00
2/5/2015Michel TimperioInsiderSell15,000C$2.11C$31,680.00
1/30/2015Bel Dominique LeInsiderSell15,000C$2.30C$34,500.00
1/29/2015Bel Dominique LeInsiderSell10,000C$2.25C$22,500.00
1/22/2015Claudie LauzonInsiderSell8,334C$2.04C$16,966.36
1/22/2015Pierre LemieuxDirectorSell11,250C$2.00C$22,500.00
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neptune Technologies & Bioressources (TSE:NTB)
DateHeadline
seekingalpha.com logoFiscal Year 2017 Brings New Krill Oil Development (TSE:NTB)
seekingalpha.com - August 8 at 6:43 PM
finance.yahoo.com logoAcasti Announces the Election of its Directors, Change of Fiscal Year End and Other Related Matters Passed at its AGM (TSE:NTB)
finance.yahoo.com - July 15 at 12:26 PM
finance.yahoo.com logoEdited Transcript of NTB.TO earnings conference call or presentation 12-Jul-16 12:00pm GMT (TSE:NTB)
finance.yahoo.com - July 12 at 11:48 AM
News IconGeneral Mills Inc said late Monday it is recalling one of its Betty Crocker brand cake mixes from Canadian markets because of a possible E (TSE:NTB)
www.ad-hoc-news.de - July 12 at 10:50 AM
finance.yahoo.com logoNeptune Announces First Quarter Results (TSE:NTB)
finance.yahoo.com - July 12 at 10:50 AM
finanznachrichten.de logoNeptune Announces First Quarter Results / Record Revenues and EBITDA for the Quarter in the Nutraceutical Segment (TSE:NTB)
www.finanznachrichten.de - July 11 at 6:31 PM
4-traders.com logoNeptune Technologies & Bioressources : Announces First Quarter Results (TSE:NTB)
www.4-traders.com - July 11 at 6:31 PM
biz.yahoo.com logoQ1 2017 Neptune Technologies & Bioressources Inc Earnings Release - After Market Close (TSE:NTB)
biz.yahoo.com - July 11 at 7:07 AM

Social

Neptune Technologies & Bioressources (TSE:NTB) Chart for Sunday, August, 28, 2016


Last Updated on 8/28/2016 by MarketBeat.com Staff